4-Tert-Butylbenzenesulfonamide

We are 4-Tert-Butylbenzenesulfonamide CAS:6292-59-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Tert-Butylbenzenesulfonamide
CAS.NO:6292-59-7
Synonyms:4-Tert-Butylbenzenesulfonamide
4-(2-Methyl-2-propanyl)benzenesulfonamide
4-(tert-butyl)benzene-1-sulfonamide
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 337.2±35.0 °C at 760 mmHg
Melting Point 136-138°C
Molecular Formula C10H15NO2S
Molecular Weight 213.297
Flash Point 157.7±25.9 °C
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.536
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Bosentan(CAS:147536-97-8).

4-Tert-Butylbenzenesulfonamide


Related News: With the continuous advancement of economic globalization, the division of labor and cooperation around the world has become increasingly apparent. The fine chemical industry has the foundation of global division of labor and cooperation due to its long and complex industrial chain.5-amino-2-metilfenol, ácido sulfúrico CAS:183293-62-1 Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity.22374-89-6 Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity.6-Acetoxy-4-chloro-7-methoxyquinazoline CAS:230955-75-6 “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.“CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.

Related Products
Product Name
N-([1,1′-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine View Details
4-Nitrophenylethylamine Hydrobromide View Details
2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethanamine View Details
acetoin manufacturer N-Isobutyl-3-nitroquinolin-4-amine manufacturer tert-butyl 2-bromo-2-methylpropanoate manufacturer N,N’-Bis(9-Fluorenylmethyloxycarbonyl)-L-Histidine manufacturer (3S,4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-3-hydroxy-6-methylheptanoic acid manufacturer